Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxomaperitonei: A study of timingandthe impact of malignant dedifferentiation
Chua TC, Al-Zahrani A, Saxena A, et al. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxomaperitonei: a study of timingandthe impact of malignant dedifferentiation. J Am Coll Surg 2010;211:526-535.
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"
Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei." Am J Surg Pathol 1995;19:1390-1408.
Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review
DOI 10.1097/01.pas.0000202039.74837.7d, PII 0000047820060500000001
Bradley RF, Stewart JH 4th, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551-559. (Pubitemid 44265007)
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: Failure versus success with a second-look operation
DOI 10.1038/modpathol.3880276
Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol 2001;14:164-171. (Pubitemid 32246819)